U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX21026451: GSM6605749: KU111t; Homo sapiens; RNA-Seq
1 ILLUMINA (NextSeq 500) run: 14.3M spots, 1.1G bases, 412Mb downloads

External Id: GSM6605749_r1
Submitted by: University of Texas Southwestern Medical Center
Study: Transcriptome profile of hepatocellular carcinoma from non-alcoholic fatty liver.
show Abstracthide Abstract
Non-alcoholic fatty liver disease (NAFLD) is a major global health problem with its high prevalence and risk of developing lethal complications, progressive liver fibrosis and hepatocellular carcinoma (HCC), the only rising cancer mortality in the U.S. Ever after curative surgical resection, HCC can recur at extremely high rate (70% within 5 years); therefore, prediction of recurrent HCC is expected to guide decision of neo/adjuvant therapies currently under active development. Herein, we derived an HCC-transcriptome-based signature to predict disseminative recurrence, which originates from disseminated HCC cells from surgically resected initial tumor, and validated it in an independent cohort. Overall design: HCC tumor tissues were obtained from 45 patients who underwent surgically curative resection and used for RNA isolation and genome-wide transcriptome profiling by RNA-Seq.
Sample: KU111t
SAMN36458031 • SRS18298866 • All experiments • All runs
Organism: Homo sapiens
Library:
Name: GSM6605749
Instrument: NextSeq 500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: RNA was isolated from 10 micron-thick FFPE tissue using High Pure RNA Paraffin kit (Roche) according to manufacturer's protocol. Truseq RNA Exome kit (Illumina, CA) following manufacturer's protocol. Exome-enriched RNA-seq
Runs: 1 run, 14.3M spots, 1.1G bases, 412Mb
Run# of Spots# of BasesSizePublished
SRR2528152614,321,4291.1G412Mb2023-09-14

ID:
28461044

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...